Analysts Conflicted on These Healthcare Names: Teladoc (TDOC) and Alcon (ALC)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Teladoc (TDOC – Research Report) and Alcon (ALC – Research Report).
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Teladoc (TDOC)
Wells Fargo analyst Stan Berenshteyn maintained a Hold rating on Teladoc yesterday and set a price target of $6.00. The company’s shares closed last Wednesday at $4.65.
According to TipRanks.com, Berenshteyn has 0 stars on 0-5 stars ranking scale with an average return of
Teladoc has an analyst consensus of Hold, with a price target consensus of $7.56, which is a 63.6% upside from current levels. In a report issued on February 18, BTIG also maintained a Hold rating on the stock.
See today’s best-performing stocks on TipRanks >>
Alcon (ALC)
According to TipRanks.com, Biegelsen is a 3-star analyst with an average return of
Currently, the analyst consensus on Alcon is a Moderate Buy with an average price target of $96.34, a 13.0% upside from current levels. In a report issued on February 18, BTIG also maintained a Buy rating on the stock with a $91.00 price target.
